GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Cyclically Adjusted Price-to-FCF

Quest Diagnostics (BSP:Q1UE34) Cyclically Adjusted Price-to-FCF : 14.50 (As of Jun. 06, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Cyclically Adjusted Price-to-FCF?

As of today (2024-06-06), Quest Diagnostics's current share price is R$328.82. Quest Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was R$22.68. Quest Diagnostics's Cyclically Adjusted Price-to-FCF for today is 14.50.

The historical rank and industry rank for Quest Diagnostics's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSP:Q1UE34' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.42   Med: 17.23   Max: 23.29
Current: 15.55

During the past years, Quest Diagnostics's highest Cyclically Adjusted Price-to-FCF was 23.29. The lowest was 11.42. And the median was 17.23.

BSP:Q1UE34's Cyclically Adjusted Price-to-FCF is ranked better than
73.02% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.38 vs BSP:Q1UE34: 15.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Quest Diagnostics's adjusted free cash flow per share data for the three months ended in Mar. 2024 was R$1.112. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is R$22.68 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Quest Diagnostics Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Quest Diagnostics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Cyclically Adjusted Price-to-FCF Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.22 19.27 23.04 18.84 15.35

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.81 16.20 13.97 15.35 14.50

Competitive Comparison of Quest Diagnostics's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Quest Diagnostics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Cyclically Adjusted Price-to-FCF falls into.



Quest Diagnostics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Quest Diagnostics's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=328.82/22.68
=14.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Quest Diagnostics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.112/131.7762*131.7762
=1.112

Current CPI (Mar. 2024) = 131.7762.

Quest Diagnostics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.781 100.560 2.334
201409 1.362 100.428 1.787
201412 1.964 99.070 2.612
201503 -0.043 99.621 -0.057
201506 2.404 100.684 3.146
201509 2.153 100.392 2.826
201512 2.382 99.792 3.145
201603 1.361 100.470 1.785
201606 3.062 101.688 3.968
201609 2.749 101.861 3.556
201612 2.690 101.863 3.480
201703 1.708 102.862 2.188
201706 2.695 103.349 3.436
201709 3.345 104.136 4.233
201712 2.836 104.011 3.593
201803 1.262 105.290 1.579
201806 3.323 106.317 4.119
201809 4.744 106.507 5.870
201812 2.012 105.998 2.501
201903 3.219 107.251 3.955
201906 3.345 108.070 4.079
201909 3.052 108.329 3.713
201912 2.656 108.420 3.228
202003 2.968 108.902 3.591
202006 5.207 108.767 6.309
202009 15.195 109.815 18.234
202012 7.169 109.897 8.596
202103 13.462 111.754 15.874
202106 7.444 114.631 8.557
202109 9.967 115.734 11.349
202112 7.623 117.630 8.540
202203 8.575 121.301 9.316
202206 6.914 125.017 7.288
202209 8.532 125.227 8.978
202212 4.265 125.222 4.488
202303 -0.761 127.348 -0.787
202306 7.238 128.729 7.409
202309 2.209 129.860 2.242
202312 9.953 129.419 10.134
202403 1.112 131.776 1.112

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Quest Diagnostics  (BSP:Q1UE34) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Quest Diagnostics Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (BSP:Q1UE34) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines